BOSTON (EGMN) – Fidaxomicin is superior to vancomycin for the treatment of recurrent Clostridium difficile infection, investigators reported Sept. 14 at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
BOSTON (EGMN) – Fidaxomicin is superior to vancomycin for the treatment of recurrent Clostridium difficile infection, investigators reported Sept. 14 at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy.